Solution Briefs

This industry solution brief shares key insights on how life sciences organizations can drive innovation with trusted data, speed data discovery, improve data literacy and data integrity at scale across R&D and commercial operations.

Below is an excerpt from the brief. To read the full brief, [click here]

Pharmaceuticals, biotech firms and medical device manufacturers operate in a highly complex data landscape. Many are grappling with a combination of data sprawl and data silos whereby data resides in hundreds of disparate data sources across an on-premises and multi-cloud ecosystem.

In this type of environment, it is very difficult for data citizens – including chief data officers, clinical researchers, data scientists, data governance leads, data engineers and data consumers – to easily find or understand the data they need. Users are unable to ascertain if the data comes from a trustworthy source and whether it is certified for use. They are unable to obtain detailed information about the data such as its attributes, where did it originate from, who owns the data and whether it is of high or poor quality.

Since life sciences organizations operate in a highly regulated industry, data integrity issues coupled with a lack of data governance, transparency and traceability of data can elevate both operational and regulatory non-compliance risks.